These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30454704)

  • 1. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
    Lei L; Hu H; Lei Y; Feng J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):668-673. PubMed ID: 30454704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.
    Kain V; Kumar S; Sitasawad SL
    Cardiovasc Diabetol; 2011 Nov; 10():97. PubMed ID: 22054019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
    Norby FL; Wold LE; Duan J; Hintz KK; Ren J
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E658-66. PubMed ID: 12217882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
    Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
    Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes.
    Norby FL; Aberle NS; Kajstura J; Anversa P; Ren J
    J Endocrinol; 2004 Jan; 180(1):175-82. PubMed ID: 14709156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload.
    Wang JW; Fontes MSC; Wang X; Chong SY; Kessler EL; Zhang YN; de Haan JJ; Arslan F; de Jager SCA; Timmers L; van Veen TAB; Lam CSP; Kleijn DPV
    Sci Rep; 2017 Aug; 7(1):9193. PubMed ID: 28835616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme.
    Wold LE; Ceylan-Isik AF; Fang CX; Yang X; Li SY; Sreejayan N; Privratsky JR; Ren J
    Free Radic Biol Med; 2006 Apr; 40(8):1419-29. PubMed ID: 16631532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
    Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
    Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac metallothionein overexpression improves cardiac contractile function and attenuates oxidative stress in lipopolysaccharide-treated mice].
    Zhao P; Zhang J; Chu X; Yuan HT; Cui LQ; Zhu XL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):711-6. PubMed ID: 22169416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus.
    Ceylan-Isik AF; Wu S; Li Q; Li SY; Ren J
    J Appl Physiol (1985); 2006 Jan; 100(1):150-6. PubMed ID: 16166234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of yellow wine polyphenols on cardiomyocyte apoptosis in diabetic cardiomyopathy rats].
    Pan SL; Lin H; Luo HQ; Gao FD; Meng LP; Guo Y; Guo HY; Chi JF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):431-435. PubMed ID: 29926588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase differentially regulates contractile function in cardiac myocytes from normotensive and spontaneously hypertensive rats: role of Ca2+ regulatory proteins.
    Li SY; Golden KL; Jiang Y; Wang GJ; Privratsky JR; Zhang X; Eason AR; Culver B; Ren J
    Cell Biochem Biophys; 2005; 42(1):1-12. PubMed ID: 15673924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
    Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
    Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
    Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes.
    Wold LE; Relling DP; Colligan PB; Scott GI; Hintz KK; Ren BH; Epstein PN; Ren J
    J Mol Cell Cardiol; 2001 Sep; 33(9):1719-26. PubMed ID: 11549350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.